摘要
目的 :评估静脉滴注拉贝洛尔治疗高血压急症的降压疗效及安全性。方法 :31例高血压急症患者接受拉贝洛尔 ( 1~ 4mg/ min,iv gtt)治疗。结果 :治疗前血压为 2 3.2 / 16 .5 k Pa,拉贝洛尔治疗 2 h后 90 % ( 2 8/ 31)患者平均血压下降 15 %~ 2 5 % ,治疗 6 h后血压控制在 2 1.3/ 13.3k Pa以下者为 94% ,拉贝洛尔降压起效快且无低血压现象发生。结论 :静脉滴注拉贝洛尔治疗高血压急症有效。
AIM: To evaluate the efficacy in lowering blood pressure, and the safety of intravenous drip labetalol in the treatment of Chinese hypertension emergencies. METHODS: Thirty one Chinese patients with hypertension emergencies received intravenous labetalol (1-4 mg/min). RESULTS: Pretreatment blood pressure values were 23 2/16 5 kPa. Treatment response (15%-25% decrease in mean arterial pressure after 2 h treatment) was achieved in 90% (28/31) of labetalol treated patients. After 6 h treatment, 94% patients reached goal blood pressure (<21 3/13 3 kPa). The short response time to lower blood pressure and no hypotention were observed in labetalol treated patients. CONCLUSION: It is suggested that intravenous drip labetalol is highly effective and safe in the treatment of Chinese hypertension emergencies.
出处
《中国临床药学杂志》
CAS
2001年第2期73-75,共3页
Chinese Journal of Clinical Pharmacy